Article
From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease.
Proceedings of the National Academy of Sciences of the United States of America - 29 Sept 2009
Friedman David J, Künzli Beat M, A-Rahim Yousif I, Sevigny Jean, Berberat Pascal O, Enjyoji Keiichi, Csizmadia Eva, Friess Helmut, Robson Simon C
Abstract excerpt
CD39/ENTPD1 hydrolyzes proinflammatory nucleotides to generate adenosine. As purinergic mediators have been implicated in intestinal inflammation, we hypothesized that CD39 might protect against inflammatory bowel disease. We studied these possibilities in a mouse model of colitis using mice with global CD39 deletion. We then tested whether human genetic polymorphisms in the CD39 gene might influence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
